APTO Aptose Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APTO

Price (delayed)

$1.2

Market cap

$18.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.58

Enterprise value

$10.62M

Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics ...

Highlights
The debt has contracted by 22% YoY and by 9% from the previous quarter
The EPS has declined by 11% year-on-year but it has grown by 4.2% since the previous quarter
Aptose Biosciences's equity has shrunk by 137% QoQ and by 108% YoY
The quick ratio has plunged by 84% YoY and by 57% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://aptose.com
Peers: ADXS CRBP AGEN

Key stats

What are the main financial stats of APTO
Market
Shares outstanding
15.72M
Market cap
$18.86M
Enterprise value
$10.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$51.21M
EBITDA
-$50.74M
Free cash flow
-$44.62M
Per share
EPS
-$7.58
Free cash flow per share
-$6.61
Book value per share
-$0.37
Revenue per share
$0
TBVPS
$1.92
Balance sheet
Total assets
$12.99M
Total liabilities
$15.89M
Debt
$1.02M
Equity
-$2.9M
Working capital
-$3.38M
Liquidity
Debt to equity
-0.35
Current ratio
0.78
Quick ratio
0.61
Net debt/EBITDA
0.16
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-205.3%
Return on equity
-458.7%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APTO stock price

How has the Aptose Biosciences stock price performed over time
Intraday
-7.69%
1 week
-14.89%
1 month
-21.05%
1 year
-84.38%
YTD
-52.76%
QTD
-27.71%

Financial performance

How have Aptose Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$52.36M
Net income
-$51.21M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 23% YoY and by 3.4% QoQ
Aptose Biosciences's net income has decreased by 22% YoY and by 4% from the previous quarter

Growth

What is Aptose Biosciences's growth rate over time

Valuation

What is Aptose Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 11% year-on-year but it has grown by 4.2% since the previous quarter
Aptose Biosciences's equity has shrunk by 137% QoQ and by 108% YoY

Efficiency

How efficient is Aptose Biosciences business performance
APTO's return on equity has dropped by 99% since the previous quarter
The return on assets has declined by 44% since the previous quarter

Dividends

What is APTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APTO.

Financial health

How did Aptose Biosciences financials performed over time
The total assets is 18% smaller than the total liabilities
The quick ratio has plunged by 84% YoY and by 57% from the previous quarter
The company's current ratio has shrunk by 81% YoY and by 51% QoQ
The debt is 135% more than the equity
Aptose Biosciences's equity has shrunk by 137% QoQ and by 108% YoY
The debt has contracted by 22% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.